Maps Public Benefit Corporation Announces Oversubscribed Series A Financing And Renames To Lykos Therapeutics
Round Type
Series A
San JoseBiotechnologyHealthcareHealth CareTherapeuticsInvestors
Description
MAPS Public Benefit Corporation ("MAPS PBC"), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing. MAPS PBC raised more than $100 million including conversion of previously issued convertible notes.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Lykos Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Biofrontera raised $8M on February 19, 2024.
- AIM ImmunoTech raised $3.3M (Seed) on February 16, 2024.
- Vaccinex raised $3.7M (Seed) on February 8, 2024.
- TuHURA Biosciences raised $1.7M (Seed) on December 11, 2023.
- Os Therapies raised $700K on December 8, 2023.
- Phio Pharmaceuticals raised $533K (Seed) on December 8, 2023.
Who to call at Lykos Therapeutics, and when
A new round usually means Lykos Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lykos Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lykos Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lykos Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lykos Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLykos Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.